​

Funding Round

Venture Round - Curocell

Venture Round - Curocell

Investment Firm

Overview

Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments.

Announced Date

Jan 04, 2022

Funding Type

Series Unknown

Highlights

Location

Asia

Social

N/A

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorRKPSG
Participant InvestorQuad Asset Management
Participant InvestorMoonchase Asset Management
Participant InvestorSeoul Investment Partners
Participant InvestorDS Asset Management

Round Details and Background

Curocell raised $30062655 on 2022-01-04 in Venture Round

Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2018
Venture Round - Curocell
1-undefined
Jan 04, 2022
Venture Round - Curocell
9-30.1M
Aug 10, 2020
Series C - Curocell
15-37.1M
Oct 01, 2018
Venture Round - Curocell
1-undefined

Recent Activity

There is no recent news or activity for this profile.